Effects of an extracellular metal chelator on neurovascular function in diabetic rats

Norman E Cameron, Mary Anne Cotter

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Aims/hypothesis. Increased oxidative stress has been causally linked to diabetic neurovascular complications? which are attenuated by antioxidants. There are several possible sources of reactive oxygen species in diabetes. Our aim was to assess the contribution of free radicals, produced by transition metal catalysed reactions, to early neuropathic changes. To this end, we examined, firstly the effects of an extracellular high molecular weight chelator, hydroxyethyl starch-deferoxamine, which is expected to be confined to vascular space, on nerve perfusion and conduction deficits in diabetic rats and, secondly, the action of a single chelator dose.

Methods. Diabetes was induced by streptozotocin. In vivo measurements comprised sciatic nerve motor conduction velocity and endoneurial perfusion, monitored by hydrogen clearance microelectrode polarography.

Results. We found that 8 weeks of diabetes reduced sciatic blood flow and conduction velocity by 48.3 and 19.9 respectively, Two weeks of intravenous treatment corrected these deficits. Starch vehicle was ineffective. The time-course of action of a single hydroxyethyl starch-deferoxamine injection was examined in diabetic rats. There was a rapid increase in nerve blood flow on day 1, which remained within the non-diabetic range for 9 days before declining to the diabetic level at day 27. Tn contrast, conduction velocity changes were slower reaching the non-diabetic range at day 6 and declining to the diabetic level at day 27.

Conclusion/interpretation. Extracellular transition metal catalysed reactions play a major role in the neurovascular deficits of experimental diabetes. Given the long-lasting effect of a single treatment, extracellular metal chelator therapy could be suitable for further assessment in clinical trials.

Original languageEnglish
Pages (from-to)621-628
Number of pages7
JournalDiabetologia
Volume44
Issue number5
DOIs
Publication statusPublished - Apr 2001

Keywords

  • neuropathy
  • nerve conduction
  • blood flow
  • oxidative stress
  • iron
  • copper
  • chelator
  • deferoxamine
  • diabetic rat
  • NERVE-CONDUCTION-VELOCITY
  • INDUCED ENDOTHELIAL DYSFUNCTION
  • ALDOSE REDUCTASE INHIBITION
  • NITRIC-OXIDE
  • BLOOD-FLOW
  • PERIPHERAL-NERVE
  • OXIDATIVE STRESS
  • CONJUGATED-DEFEROXAMINE
  • RADICAL SCAVENGER
  • POLYOL PATHWAY

Cite this

Effects of an extracellular metal chelator on neurovascular function in diabetic rats. / Cameron, Norman E; Cotter, Mary Anne.

In: Diabetologia, Vol. 44, No. 5, 04.2001, p. 621-628.

Research output: Contribution to journalArticle

Cameron, Norman E ; Cotter, Mary Anne. / Effects of an extracellular metal chelator on neurovascular function in diabetic rats. In: Diabetologia. 2001 ; Vol. 44, No. 5. pp. 621-628.
@article{619a180e2e43421ea1d2b76f9c4822f0,
title = "Effects of an extracellular metal chelator on neurovascular function in diabetic rats",
abstract = "Aims/hypothesis. Increased oxidative stress has been causally linked to diabetic neurovascular complications? which are attenuated by antioxidants. There are several possible sources of reactive oxygen species in diabetes. Our aim was to assess the contribution of free radicals, produced by transition metal catalysed reactions, to early neuropathic changes. To this end, we examined, firstly the effects of an extracellular high molecular weight chelator, hydroxyethyl starch-deferoxamine, which is expected to be confined to vascular space, on nerve perfusion and conduction deficits in diabetic rats and, secondly, the action of a single chelator dose.Methods. Diabetes was induced by streptozotocin. In vivo measurements comprised sciatic nerve motor conduction velocity and endoneurial perfusion, monitored by hydrogen clearance microelectrode polarography.Results. We found that 8 weeks of diabetes reduced sciatic blood flow and conduction velocity by 48.3 and 19.9 respectively, Two weeks of intravenous treatment corrected these deficits. Starch vehicle was ineffective. The time-course of action of a single hydroxyethyl starch-deferoxamine injection was examined in diabetic rats. There was a rapid increase in nerve blood flow on day 1, which remained within the non-diabetic range for 9 days before declining to the diabetic level at day 27. Tn contrast, conduction velocity changes were slower reaching the non-diabetic range at day 6 and declining to the diabetic level at day 27.Conclusion/interpretation. Extracellular transition metal catalysed reactions play a major role in the neurovascular deficits of experimental diabetes. Given the long-lasting effect of a single treatment, extracellular metal chelator therapy could be suitable for further assessment in clinical trials.",
keywords = "neuropathy, nerve conduction, blood flow, oxidative stress, iron, copper, chelator, deferoxamine, diabetic rat, NERVE-CONDUCTION-VELOCITY, INDUCED ENDOTHELIAL DYSFUNCTION, ALDOSE REDUCTASE INHIBITION, NITRIC-OXIDE, BLOOD-FLOW, PERIPHERAL-NERVE, OXIDATIVE STRESS, CONJUGATED-DEFEROXAMINE, RADICAL SCAVENGER, POLYOL PATHWAY",
author = "Cameron, {Norman E} and Cotter, {Mary Anne}",
year = "2001",
month = "4",
doi = "10.1007/s001250051669",
language = "English",
volume = "44",
pages = "621--628",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "5",

}

TY - JOUR

T1 - Effects of an extracellular metal chelator on neurovascular function in diabetic rats

AU - Cameron, Norman E

AU - Cotter, Mary Anne

PY - 2001/4

Y1 - 2001/4

N2 - Aims/hypothesis. Increased oxidative stress has been causally linked to diabetic neurovascular complications? which are attenuated by antioxidants. There are several possible sources of reactive oxygen species in diabetes. Our aim was to assess the contribution of free radicals, produced by transition metal catalysed reactions, to early neuropathic changes. To this end, we examined, firstly the effects of an extracellular high molecular weight chelator, hydroxyethyl starch-deferoxamine, which is expected to be confined to vascular space, on nerve perfusion and conduction deficits in diabetic rats and, secondly, the action of a single chelator dose.Methods. Diabetes was induced by streptozotocin. In vivo measurements comprised sciatic nerve motor conduction velocity and endoneurial perfusion, monitored by hydrogen clearance microelectrode polarography.Results. We found that 8 weeks of diabetes reduced sciatic blood flow and conduction velocity by 48.3 and 19.9 respectively, Two weeks of intravenous treatment corrected these deficits. Starch vehicle was ineffective. The time-course of action of a single hydroxyethyl starch-deferoxamine injection was examined in diabetic rats. There was a rapid increase in nerve blood flow on day 1, which remained within the non-diabetic range for 9 days before declining to the diabetic level at day 27. Tn contrast, conduction velocity changes were slower reaching the non-diabetic range at day 6 and declining to the diabetic level at day 27.Conclusion/interpretation. Extracellular transition metal catalysed reactions play a major role in the neurovascular deficits of experimental diabetes. Given the long-lasting effect of a single treatment, extracellular metal chelator therapy could be suitable for further assessment in clinical trials.

AB - Aims/hypothesis. Increased oxidative stress has been causally linked to diabetic neurovascular complications? which are attenuated by antioxidants. There are several possible sources of reactive oxygen species in diabetes. Our aim was to assess the contribution of free radicals, produced by transition metal catalysed reactions, to early neuropathic changes. To this end, we examined, firstly the effects of an extracellular high molecular weight chelator, hydroxyethyl starch-deferoxamine, which is expected to be confined to vascular space, on nerve perfusion and conduction deficits in diabetic rats and, secondly, the action of a single chelator dose.Methods. Diabetes was induced by streptozotocin. In vivo measurements comprised sciatic nerve motor conduction velocity and endoneurial perfusion, monitored by hydrogen clearance microelectrode polarography.Results. We found that 8 weeks of diabetes reduced sciatic blood flow and conduction velocity by 48.3 and 19.9 respectively, Two weeks of intravenous treatment corrected these deficits. Starch vehicle was ineffective. The time-course of action of a single hydroxyethyl starch-deferoxamine injection was examined in diabetic rats. There was a rapid increase in nerve blood flow on day 1, which remained within the non-diabetic range for 9 days before declining to the diabetic level at day 27. Tn contrast, conduction velocity changes were slower reaching the non-diabetic range at day 6 and declining to the diabetic level at day 27.Conclusion/interpretation. Extracellular transition metal catalysed reactions play a major role in the neurovascular deficits of experimental diabetes. Given the long-lasting effect of a single treatment, extracellular metal chelator therapy could be suitable for further assessment in clinical trials.

KW - neuropathy

KW - nerve conduction

KW - blood flow

KW - oxidative stress

KW - iron

KW - copper

KW - chelator

KW - deferoxamine

KW - diabetic rat

KW - NERVE-CONDUCTION-VELOCITY

KW - INDUCED ENDOTHELIAL DYSFUNCTION

KW - ALDOSE REDUCTASE INHIBITION

KW - NITRIC-OXIDE

KW - BLOOD-FLOW

KW - PERIPHERAL-NERVE

KW - OXIDATIVE STRESS

KW - CONJUGATED-DEFEROXAMINE

KW - RADICAL SCAVENGER

KW - POLYOL PATHWAY

U2 - 10.1007/s001250051669

DO - 10.1007/s001250051669

M3 - Article

VL - 44

SP - 621

EP - 628

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 5

ER -